Compare Novartis AG (NVS) vs Okta, Inc. (OKTA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Novartis AG vs Okta, Inc. — how do they compare? Novartis AG trades at $153.88 (market cap $290.25B), while Okta, Inc. trades at $141.5 (market cap $25.79B). The key difference: Novartis AG is far larger — about 11.3× Okta, Inc.'s market cap, and Novartis AG pays a 3.17% dividend while Okta, Inc. pays none. Which is the better fit depends on your goals.
| NVS | OKTA | |
|---|---|---|
Market Cap | $290.25B | $25.79B |
Sector | Health | Technology |
52-Week High | $168.62 | $154.62 |
52-Week Low | $113.50 | $62.93 |
Enterprise Value | $330.27B | $23.62B |
Dividend Yield | 3.17% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Novartis AG
Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.
Read more on NVS →About Okta, Inc.
Okta is a cloud-native security company that focuses on identity and access management. The San Francisco-based firm went public in 2017 and focuses on two key client stakeholder groups: workforces and customers. Okta's workforce offerings enable a company's employees to securely access its cloud-based and on-premises resources. The firm's customer offerings allow its clients' customers to securely access the client's applications.
Read more on OKTA →
